Genotypes Control(n=160) Cases (n=160) OR*(95% CI)
CC (ref) 60 33 1
TT 22 52 4.3(2.2-8.3)
CT 78 75 1.7(1.0-3.0)
CT+TT 100 127 2.3(1.4-3.8)
*OR–Odds ratio
Table 3: Risk of NSCLC associated with the CASP9 (-712C>T) genotypes.